secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001193125-24-154347
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma prices $1.5B senior notes offering across three tranches
-----------------------------------------------------------------------

- Issued $500M 5.150% Senior Notes due 2029, $500M 5.400% due 2034, and $500M 5.900% due 2054.
- Notes are senior unsecured and guaranteed by Royalty Pharma Holdings Ltd.
- Offering expected to close on June 10, 2024, subject to customary conditions.
- Underwriting agreement with BofA, Citigroup, J.P. Morgan, Morgan Stanley, and TD Securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312524154347/0001193125-24-154347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312524154347/d821949d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-154347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer